Clinical Trial Update: Rituximab in Patients With ST-elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rituximab in patients with ST-segment elevation myocardial infarction; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: ST Elevated Myocardial Infarction | Phase 2 | Status: RECRUITING